Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
Fase 3
ClinicalTrials.gov
APOLLO: A Phase 3 Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Patisiran (ALN-TTR02) in Transthyretin (TTR)-Mediated Polyneuropathy (Familial Amyloidotic Polyneuropathy-FAP)
INTERVENTIONAL
Inicio: 1 de nov de 2013
ID: NCT01960348
Terminado
Fase 3
ClinicalTrials.gov
A PROSPECTIVE, RANDOMIZED,OPEN-LABEL, COMPARATIVE STUDY TO ASSESS THE EFFICACY, SAFETY AND TOLERABILITY OF AZTREONAM- AVIBACTAM (ATM-AVI) AND BEST AVAILABLE THERAPY FOR THE TREATMENT OF SERIOUS INFECTIONS DUE TO MULTI-DRUG RESISTANT GRAM- NEGATIVE BACTERIA PRODUCING METALLO -Β-LACTAMASE (MBL)
INTERVENTIONAL
Inicio: 25 de dic de 2020
ID: NCT03580044
Completado
Fase 3
ClinicalTrials.gov
Immunogenicity, Reactogenicity & Safety of a Booster Dose of GSK Biologicals' DTPw-HBV/Hib Kft Vaccine Vs GSK Biologicals' DTPw-HBV/Hib Vaccine, in Infants Who Received a 3-Dose Primary Vaccination Course With the Same Vaccines.
INTERVENTIONAL
Inicio: 1 de jun de 2006
ID: NCT00332566
Terminado
Fase 2
ClinicalTrials.gov
An Open Label, Multicenter, Single Arm Study of Pasireotide LAR in Patients With Rare Tumors of Neuroendocrine Origin
INTERVENTIONAL
Inicio: 1 de sept de 2009
ID: NCT00958841
Completado
ClinicalTrials.gov
Analysis of the Pre- and Post-prandial Levels of Appetite Regulatory Hormones in Adult Individuals
INTERVENTIONAL
Inicio: 1 de sept de 2021
ID: NCT05815641
Completado
ClinicalTrials.gov
Impact of Tidal Volume Magnitude in Pressure Support Mode on Mortality in Adults Under Invasive Mechanical Ventilation. Multi-center Retrospective Cohort Study.
OBSERVATIONAL
Inicio: 30 de nov de 2023
ID: NCT06195475
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase III/IV Factorial Randomized Double-blind Trial to Compare the Addition of Dapagliflozin vs Placebo and Rosuvastatin/Ezetimibe Versus Pitavastatin in Patients With HIV on Integrase Strand Transfer Inhibitor-based Antiretrovirals With Elevated Metabolic Risk
INTERVENTIONAL
Inicio: 16 de dic de 2024
ID: NCT06317051
Completado
ClinicalTrials.gov
Observational Study to Assess the Prevalence of Spasticity and the Impact on the Quality of Life in Patients With Multiple Sclerosis in Argentina
OBSERVATIONAL
Inicio: 1 de ago de 2008
ID: NCT01080040
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus
INTERVENTIONAL
Inicio: 1 de oct de 2006
ID: NCT00391209
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
INTERVENTIONAL
Inicio: 1 de dic de 2007
ID: NCT00580216
Aún no recluta
ClinicalTrials.gov
Comprehensive Program for Hereditary Transthyretin Amyloidosis
OBSERVATIONAL
Inicio: 1 de oct de 2025
ID: NCT07213297
Completado
Fase 3
ClinicalTrials.gov
Randomized, Double-blind, Evaluation in Secondary Stroke Prevention Comparing the EfficaCy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, Oral b.i.d.) Versus Acetylsalicylic Acid (100 mg Oral q.d.) in Patients With Embolic Stroke of Undetermined Source (RESPECT ESUS)
INTERVENTIONAL
Inicio: 27 de nov de 2014
ID: NCT02239120
Desconocido
ClinicalTrials.gov
Knowledge, Professional Experience and Attitude Toward Organ Donation Among Health Care Professionals in Argentina: the DonAR Survey
OBSERVATIONAL
Inicio: 16 de feb de 2018
ID: NCT03458052
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Double-blind, Randomized, Placebo-controlled, Four-arm, Multicenter, Dose-finding Study to Assess the Safety and Efficacy of Three Dose Levels of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Central Neuropathic Pain in Patients With Multiple Sclerosis
INTERVENTIONAL
Inicio: 8 de sept de 2011
ID: NCT01324232
Completado
Fase 2
ClinicalTrials.gov
A Randomized, Double Blind, Double Dummy, Parallel Group, Placebo Controlled Study to Evaluate the Pharmacodynamic and Pharmacokinetic Response and Safety and Tolerability of SB424323 (250mg, 375mg and 500 mg) Administered Twice Daily for 16 Weeks, on Top of Asprin (325mg, qd) in Men and Women With Non Valvular Atrial Fibrillation at a Low or Intermediate Risk for Stroke
INTERVENTIONAL
Inicio: 1 de nov de 2005
ID: NCT00240643
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Double-blind, Randomized, Parallel-group Evaluation of LAMICTAL Extended-Release Adjunctive Therapy in Patients With Primary Generalized Tonic-Clonic Seizures
INTERVENTIONAL
Inicio: 1 de dic de 2004
ID: NCT00104416
Terminado
Fase 3
ClinicalTrials.gov
A Phase Iii, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Efficacy And Safety Trial Of Bapineuzumab (Aab 001, Eln115727) In Subjects With Mild To Moderate Alzheimer Disease Who Are Apolipoprotein E 4 Carriers
INTERVENTIONAL
Inicio: 1 de ene de 2008
ID: NCT00676143
Completado
ClinicalTrials.gov
XANTUS-EL, Xarelto® on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Patients With Non-valvular Atrial Fibrillation in Eastern EU, Middle East, Africa (EMEA) and Latin America (LATAM): A Non-interventional Study
OBSERVATIONAL
Inicio: 14 de ene de 2013
ID: NCT01800006
Reclutando
Fase 3
ClinicalTrials.gov
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
INTERVENTIONAL
Inicio: 11 de jul de 2023
ID: NCT05980949
Completado
ClinicalTrials.gov
Mortality and Neurologic Complications Associated With Rapid Versus Slow Correction of Hyponatremia
OBSERVATIONAL
Inicio: 1 de mar de 2024
ID: NCT06675591
Anterior
1
...
18
19
20
...
434
Siguiente
Filtros